Concepedia
Statistics
Publications
25
Citations
2.2K
H-Index
21
Active since
1969
Affiliations
Novartis (United Kingdom)(Current)
Novartis (United States)
Novartis (Switzerland)
Johannes Gutenberg University Mainz
North Carolina Clinical Research
Roger Owen is an author at Novartis (United Kingdom) specializing in pharmacotherapy, pulmonology, and obstructive lung disease.
Publications per year
1969–2012
Once-Daily Bronchodilators for Chronic Obstructive Pulmonary Disease: Indacaterol Versus Tiotropium
James F. Donohue, Charles Fogarty, Jan Lötvall et al. · American Journal of Respiratory and Critical Care Medicine · 2010 · 356 citations
Pharmacy, Pharmacotherapy, Pulmonary Function Testing +16
A Bayesian Sequential Procedure for Quantal Response in the Context of Adaptive Mental Testing
Roger Owen · Journal of the American Statistical Association · 1975 · 287 citations
Public Health, Biostatistics, Psychology +15
Efficacy of a new once-daily long-acting inhaled 2-agonist indacaterol versus twice-daily formoterol in COPD
Ronald Dahl, Kian Fan Chung, Roland Buhl et al. · Thorax · 2010 · 274 citations · Full text
Medicine, Pharmacology, Pharmacotherapy +17
Once-daily indacaterol<i>versus</i>twice-daily salmeterol for COPD: a placebo-controlled comparison
Oliver Kornmann, Ronald Dahl, Stefano Centanni et al. · European Respiratory Journal · 2010 · 213 citations · Full text
Medicine, Internal Medicine, Pharmacotherapy +17
Long-term Safety and Efficacy of Indacaterol, a Long-Acting β2-Agonist, in Subjects With COPD
Kenneth R. Chapman, Stephen I. Rennard, Roger Owen et al. · CHEST Journal · 2011 · 124 citations
Medicine, Pharmacology, Pharmacotherapy +13
1–5 of 25